home2

previous arrow
next arrow
Slider
On Microdose TherapyTM, I feel like someone Teflon-coated and greased my joints.

Helen Foundation Recommends Microdose Therapytm as Superior and Safe for Cortisone-responding Diseases

Microdose Therapytm eliminates pain, fatigue, and related inflammation symptoms in days from cortisone-responding diseases such as arthritis, asthma, dementia, fibromyalgia, MS, osteoarthritis, and Parkinson’s disease

Cortisone, the medicine used in MICRODOSE THERAPYTM, is the physician’s first choice to bring the chronic inflammation of cortisone-responding diseases under control. Since the body makes extra cortisone when stressed to deal with the stress, cortisone has become known as the stress hormone.

Fear of cortisone side effects causes physicians switch to another medicine for maintenance after achieving control using cortisone. However, no medicine has been able to maintain control satisfactory.

The good news is that a recent scientific discovery allows cortisone (properly hydrocortisone) to also be used for maintenance. The discovery is: sometimes the body loses its ability to make the extra hydrocortisone when stressed. Then inflammation goes out-of-control, and one or more of pain, fatigue, stiffness, breathing problems, movement difficulty, nerve misbehaviour, brain fog, and sleep disturbance sets in. Before this discovery, these symptoms were categorised into separate diseases such as arthritis, asthma, fibromyalgia, multiple sclerosis, osteoarthritis, and Parkinson’s disease. Since these respond to cortisone administration, they are the cortisone-responding diseases. Symptoms vary according to where the inflammation located: asthma if it is in the lungs; osteoarthritis if it is in the joints; Parkinson’s disease if it is in the brain, and so forth.

The solution to cortisone-responding diseases is simple: for maintenance teach patients when, how much and for what reasons to take hydrocortisone to replace the missing hydrocortisone (MICRODOSE THERAPY). Five of six lose symptoms in three weeks. Remission is possible.

When patients are in control of hydrocortisone, they use so little that cortisone side effects do not appear. Cortisone side effects familiar to physicians are due to hydrocortisone over dosing through not knowing how to use cortisone. In proof that MICRODOSE THERAPY solves cortisone side effects, no significant cortisone side effects were observed during the 2,430-participant MICRODOSE THERAPY clinical trial.

The FDA now recommends hydrocortisone be used in accord with the MICRODOSE THERAPY treatment plan for cortisone-responding diseases.

Since hydrocortisone is generic and low cost, there has been no other organization other than the Helen Foundation willing to inform patients about MICRODOSE THERAPY. The Helen Foundation also provides the education program and recommended dosages essential for success of MICRODOSE THERAPY. Dosage must be customized for disease type, disease severity, age, sex, and body weight.

Fibromyalgia

Moderate to Severe Fibromyalgia: In medical studies, MICRODOSE THERAPY was shown to be clinically effective in about 5 out of 6 adults with fibromyalgia at 4 weeks. MICRODOSE THERAPY averages 77% average symptom improvement. MICRODOSE THERAPY has been shown to begin working in 1 week with maximum disease control at 6 weeks.

Request for Information

Arthritis

Moderate to Severe Arthritis: In medical studies, MICRODOSE THERAPY was shown to be clinically effective in about 5 out of 6 adults with arthritis at 4 weeks. MICRODOSE THERAPY averages 76% average symptom improvement. MICRODOSE THERAPY has been shown to begin working in 1 week with maximum disease control at 6 weeks.

Request for Information

Asthma

Moderate to Severe Asthma:In medical studies, MICRODOSE THERAPY was shown to be clinically effective in about 5 out of 6 adults with asthma at 3 weeks. MICRODOSE THERAPY averages 68% average symptom improvement. MICRODOSE THERAPY has been shown to begin working in 1 week with maximum disease control at 3 weeks.

Request for Information

Multiple Sclerosis

Moderate to Severe Multiple Sclerosis: In medical studies, MICRODOSE THERAPY was shown to be clinically effective in about 5 out of 6 adults with multiple sclerosis at 6 weeks. MICRODOSE THERAPY averages 67% average symptom improvement. MICRODOSE THERAPY has been shown to begin working in 1 week with maximum disease control at 6 weeks.

Request for Information

Osteoarthritis

Moderate to Severe Rheumatoid Arthritis: In medical studies, MICRODOSE THERAPY was shown to be clinically effective in about 5 out of 6 adults with rheumatoid arthritis at 4 weeks. MICRODOSE THERAPY averages 78% average symptom improvement. MICRODOSE THERAPY has been shown to begin working in 1 week with maximum disease control at 6 weeks.

Request for Information

Parkinson’s Disease

Moderate to Severe Parkinson’s disease: In medical studies, MICRODOSE THERAPY was shown to be clinically effective in about 5 out of 6 adults with Parkinson’s disease at 6 weeks. MICRODOSE THERAPY averages 62% average movement improvement and 67% average mental improvement. MICRODOSE THERAPY has been shown to begin working in 1 week with maximum disease control at 6 weeks.

Request for Information

Helen Foundation Recommends Microdose Therapytm as Superior and Safe for Cortisone-responding Diseases

Microdose Therapytm patient self-administration of hydrocortisone, eliminates pain, fatigue, and related inflammation symptoms within days with no significant side effects.

Helen Stenberg
For whom Microdose Therapy was created

Hench of the Mayo Clinic proved hydrocortisone perfectly controls rheumatoid arthritis for which he received the 1950 Nobel Prize. Later, hydrocortisone became restricted to emergency use because of its prohibitive side effects. Stenberg of the University of North Dakota (UND) proved the side effects are overdose effects. By using it on bad days and not on the good ones, Microdose Therapy patients reduce its use to safe levels while perfectly controlling inflammation diseases as the arthritis disease family, asthma, dementia, multiple sclerosis, neuropathy, and Parkinson’s disease – not just rheumatoid arthritis. Microdose Therapy is FDA-approved and is proven effective by clinical studies:

UND School of Medicine double-blind clinical trial: Patients averaged 75% relief with no significant side effects (about twice that of standard treatments; Fiechtner JJ, Chief of Rheumatology; published)

University of Alexandria (Egypt) School of Medicine duplicated the UND clinical trial:

Independently confirmed the UND clinical trial results (Hamdy K, Rheumatologist, published)
Helen Foundation clinical trial: 2,417 patients with 38 inflammation diseases averaged 76% relief (published; for copy, search Pubmed using “Virgil I. Stenberg, General Theory of Inflammation”)

Sigurd Adenas, 10 years on Microdose Therapy
“I feel like someone greased and teflon-coated my joints”

Experts comment: “Hydrocortisone is a hormone produced by the human adrenal cortex useful in the treatment of inflammation, allergies, and rheumatoid arthritis.” Dorland’s Medical Dictionary
“Think of hydrocortisone as your body’s stress hormone to control your mood, motivation, fear, keeping your inflammation down, controlling your sleep/wake cycle, and boosting energy.” WebMD
“Microdose Therapy, very low-dose cortisone, has very few if any side effects.” Arthritis Foundation

Helen: “I was in a prison of pain with no escape. Now, I have had no arthritis pain for years.”

Alvina Anderson: “Forget your skepticism. Oh, it worked for me perfectly! Nobody could get worse than I was. If it worked for me, why wouldn’t it work for you? What have you got to loose?”

Start Microdose Therapy complete and email the enrollment form to @helenfoundation.com. Microdose Therapy copay cost is $375. Board-certified physicians administer Microdose Therapy in partnership with your personal physician without the need of travel.

Enrollment Form

    Name*

    Email*
    Age*
    Gender*
    Address*
    City*
    State*
    Zip*
    Country*
    Phone(home)*
    (work)
    (Cell)
    Medications taken:

    Best phone time:
    Diagnosis:
    Body weight:

    Personal physician
    Phone*
    Pharmacy
    City*
    State*
    Phone*

    Scroll to top